Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system

Molecular Psychiatry

Volumn 20, Issue 6, 2015, Pages 727-734

  Clements, C C ^a   Castro, V M ^a,b   Blumenthal, S R ^a   Rosenfield, H R ^a   Murphy, S N ^a,b   Fava, M ^a   Erb, J L ^c   Churchill, S E ^b   Kaimal, A J ^a   Doyle, A E ^a   Robinson, E B ^a   Smoller, J W ^a   Kohane, I S ^c   Perlis, R H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PARTNERS HEALTHCARE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIRTH CERTIFICATE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EXPOSURE; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MATERNAL WELFARE; PREGNANCY; PRENATAL EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; PUERPERAL DEPRESSION; UNITED STATES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CASE CONTROL STUDY; ENGLAND; ETIOLOGY; MOTHER CHILD RELATION; PRESCHOOL CHILD; RISK FACTOR; STATISTICAL MODEL;

ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MOTHER-CHILD RELATIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84929863817     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.90     Document Type: Article

References (20)

1. Investigators AaDDMNSYP Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network. MMWR Surveill Summ 2012; 61: 1-19.
2. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 1995; 25: 63-77.
3. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68: 1095-1102.
4. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879-881.
5. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011; 68: 1104-1112.
6. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346: f2059.
7. Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013; 369: 2406-2415.
8. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera ACet al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499-507.
9. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63: 898-906.
10. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 2008; 121: E1357-e1362.
11. Piven J, Palmer P. Psychiatric disorder and the broad autism phenotype: Evidence from a family study of multiple-incidence autism families. Am J Psychiatry 1999; 156: 557-563.
12. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/ hyperactivity disorder in the offspring. J Dev Behav Pediatr 2010; 31: 641-648.
13. Laugesen K, Olsen MS, Telen Andersen AB, Froslev T, Sorensen HT. In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ Open 2013; 3: E003507.
14. Murphy SN, Mendis M, Hackett K, Kuttan R, Pan W, Phillips LC et al. Architecture of the open-source clinical research chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc 2007; 548-552.
15. Murphy S, Churchill S, Bry L, Chueh H, Weiss S, Lazarus R et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res 2009; 19: 1675-1681.
16. Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc 17: 124-130.
17. Castro VM, Gallagher PJ, Clements CC, Murphy SN, Gainer VS, Fava M et al. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open 2012; 2: E000544.
18. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997; 283: 1305-1322.
19. Schieve LA, Tian LH, Baio J, Rankin K, Rosenberg D, Wiggins L et al. Population attributable fractions for three perinatal risk factors for autism spectrum disorders, 2002 and 2008 autism and developmental disabilities monitoring network. Ann Epidemiol 2014; 24: 260-266.
20. Lash, TL Fox, MP Fink, AK. A Guide to Implementing Quantitative Bias Analysis. In Gail M, Krickeberg K, Samet J, Tsiatis A, Wong W (eds). Applying Quantitative Bias Analysis to Epidemiologic Data, 1st edn, Springer: New York, NY, 2009. pp 215-220.